Jason Is Volition’s Chief Medical Officer and also serves as the Chief Executive Officer of Volition America Inc. He has a strong grounding in both medicine and more specifically in diagnostics and product commercialization and has led both the clinical trial development program in the U.S. for Volition, in addition to supporting the launch of our first Veterinary product, the Nu.Q™ Vet Cancer Screening Test.
Since 2017 Jason also serves as Affiliate Faculty of the Department of Oncology at the Austin Dell Medical School, University of Texas.
He was educated at Hardin-Simmon University (Biochemistry) where he graduated Summa Cum Laude, also receiving the Holland Medal of Honor. He received his Doctor of Medicine from the University of Texas Medical School at Houston and affiliate MD Anderson Cancer Center.
Jason has been Affiliate Faculty in the Department of Oncology at the University of Texas at Austin Dell Medical School since 2017.
“Cancer doesn’t discriminate; causing fear, pain and suffering for all those it touches. Recent breakthroughs in therapeutics have made great strides. However, early diagnosis is key. If cancer is to be successfully treated it must be caught early”